|
USP47 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.40029998286462E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.44540000005067E-06 |
| Normal-vs-Stage2 |
1.438160E-03 |
| Normal-vs-Stage3 |
2.15609999854038E-08 |
| Normal-vs-Stage4 |
3.38590000004135E-06 |
| Stage1-vs-Stage2 |
9.796200E-01 |
| Stage1-vs-Stage3 |
1.122000E-01 |
| Stage1-vs-Stage4 |
3.962000E-01 |
| Stage2-vs-Stage3 |
3.107800E-01 |
| Stage2-vs-Stage4 |
5.852200E-01 |
| Stage3-vs-Stage4 |
6.558000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.76240000371308E-08 |
| Normal-vs-AfricanAmerican |
1.93439999995881E-06 |
| Normal-vs-Asian |
3.516600E-01 |
| Caucasian-vs-AfricanAmerican |
3.716200E-01 |
| Caucasian-vs-Asian |
3.440800E-01 |
| AfricanAmerican-vs-Asian |
2.203200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.21349996507325E-09 |
| Normal-vs-Female |
1.51867000000028E-05 |
| Male-vs-Female |
2.558600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.519770E-01 |
| Normal-vs-Age(41-60Yrs) |
2.25689999999723E-06 |
| Normal-vs-Age(61-80Yrs) |
1.37519995391244E-09 |
| Normal-vs-Age(81-100Yrs) |
1.233520E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.103400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.508400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.424400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.370500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.361200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.661400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.009400E-01 |
| Normal-vs-Grade 2 |
1.61030000001006E-06 |
| Normal-vs-Grade 3 |
1.54589996359533E-09 |
| Normal-vs-Grade 4 |
4.47670000000011E-05 |
| Grade 1-vs-Grade 2 |
3.450800E-01 |
| Grade 1-vs-Grade 3 |
7.613500E-02 |
| Grade 1-vs-Grade 4 |
2.481200E-01 |
| Grade 2-vs-Grade 3 |
5.959800E-02 |
| Grade 2-vs-Grade 4 |
6.398400E-01 |
| Grade 3-vs-Grade 4 |
3.670800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.48029999994471E-07 |
| Normal-vs-ccB subtype |
5.94069999999558E-05 |
| ccA subtype-vs-ccB subtype |
3.530000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.36569999975578E-07 |
| Normal-vs-N1 |
1.103000E-01 |
| N0-vs-N1 |
6.589800E-01 |
|
|
